Omada Health (NASDAQ:OMDA) Now Covered by Analysts at Citizens Jmp

Citizens Jmp initiated coverage on shares of Omada Health (NASDAQ:OMDA) in a research note published on Tuesday, MarketBeat.com reports. The brokerage issued an outperform rating and a $18.00 price objective on the stock.

Other equities research analysts have also recently issued reports about the stock. JPMorgan Chase & Co. cut their price objective on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Wells Fargo & Company started coverage on shares of Omada Health in a research report on Thursday, January 8th. They issued an “equal weight” rating and a $17.00 price objective on the stock. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Omada Health in a research report on Thursday, January 22nd. The Goldman Sachs Group cut their price objective on shares of Omada Health from $26.00 to $23.00 and set a “buy” rating on the stock in a research report on Thursday, April 9th. Finally, Canaccord Genuity Group lowered their price target on shares of Omada Health from $28.00 to $22.00 and set a “buy” rating on the stock in a research note on Friday, March 6th. Ten investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $21.64.

Omada Health Trading Up 2.8%

OMDA opened at $12.46 on Tuesday. The stock has a market capitalization of $734.14 million and a P/E ratio of -73.29. Omada Health has a 12 month low of $10.28 and a 12 month high of $28.40. The firm’s fifty day simple moving average is $12.67 and its 200 day simple moving average is $16.80.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.12. The company had revenue of $75.85 million during the quarter.

Insider Buying and Selling at Omada Health

In other Omada Health news, CFO Steven L. Cook sold 1,884 shares of Omada Health stock in a transaction on Friday, March 13th. The shares were sold at an average price of $13.94, for a total value of $26,262.96. Following the sale, the chief financial officer directly owned 200,512 shares in the company, valued at approximately $2,795,137.28. The trade was a 0.93% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, President Wei-Li Shao sold 2,829 shares of Omada Health stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $12.71, for a total transaction of $35,956.59. Following the completion of the sale, the president owned 328,850 shares in the company, valued at $4,179,683.50. The trade was a 0.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 8,776 shares of company stock worth $120,483.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the company. XTX Topco Ltd acquired a new position in shares of Omada Health during the 4th quarter worth about $297,000. Utah Retirement Systems acquired a new position in shares of Omada Health during the 4th quarter worth about $1,237,000. VARCOV Co. acquired a new position in shares of Omada Health during the 4th quarter worth about $504,000. Voloridge Investment Management LLC acquired a new position in shares of Omada Health during the 4th quarter worth about $2,590,000. Finally, Tudor Investment Corp ET AL grew its stake in Omada Health by 373.7% in the 4th quarter. Tudor Investment Corp ET AL now owns 211,416 shares of the company’s stock valued at $3,336,000 after buying an additional 166,783 shares during the last quarter.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.